EQS News EQS News
News
Feed
Events
Feed
News
+ Events
Feed

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
News Feed My Watchlists News Latest Reports Latest Research My favorite News
Events Feed Past Events Upcoming Webcasts Past Webcasts My favorite Events
Log in/Register
en

Recently viewed news

Recently viewed Companies

Search Results of news

Show all

Search Results of Companies

Show all

Search Results of events

Show all
  • ISIN DE000A1EWVY8
  • Country Deutschland

Other Capital Market Information | 11 November 2024 14:11

Formycon AG
Veröffentlichung des Herkunftsstaates gemäß § 5 WpHG mit dem Ziel der europaweiten Verbreitung

Formycon AG / Herkunftsstaat
Veröffentlichung des Herkunftsstaates gemäß § 5 WpHG mit dem Ziel der europaweiten Verbreitung
11.11.2024 / 14:11 CET/CEST
Veröffentlichung einer Zulassungsfolgepflichtmitteilung übermittelt durch EQS News – ein Service der EQS Group AG.
Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.

Die Formycon AG gibt gem. § 5 WpHG bekannt, dass Deutschland der Herkunftsstaat ist.

11.11.2024 CET/CEST Die EQS Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen.
Medienarchiv unter https://eqs-news.com
Sprache: Deutsch
Unternehmen: Formycon AG
Fraunhoferstraße 15
82152 Planegg-Martinsried
Deutschland
Internet: www.formycon.com

 
Ende der Mitteilung EQS News-Service

show this

Latest News

News Functions

Additional Functions

19 November 2024

06:30 Corporate

Formycon AG

Corporate

Formycon invites to earnings call on the nine-month results 2024 and announces participation in international investor conferences

18 November 2024

06:30 Corporate

Formycon AG

Corporate

Formycon receives positive CHMP opinion for FYB203 (aflibercept), a biosimilar candidate to Eylea® under the tradenames AHZANTIVE® and Baiama®

15 November 2024

18:18 Ad-hoc

Formycon AG

Ad-hoc

Aflibercept-Biosimilar FYB203 / AHZANTIVE®/ Baiama® receives positive CHMP Opinion from EMA

13 November 2024

13:57 Voting Rights Announcements DE

Formycon AG

Voting Rights Announcements
DE

 
13:57 Voting Rights Announcements DE

Formycon AG

Voting Rights Announcements
DE

 
More News

Latest Reports

News Functions

Additional Functions

22 October 2024

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2024

29 April 2024

Annual Report PDF

Formycon AG

Annual Report
PDF

Annual financial statements 2023

30 August 2023

Quarterly Report PDF

Formycon AG

Quarterly Report
PDF

Half-yearly financial statements 2023
More Reports

Upcoming Events

Event Functions

Additional Functions

25

Nov 24

Formycon AG

Analysts’ Conference

Frankfurt am Main

28

Nov 24

Formycon AG

Press Release – quarterly statement (call-date Q3)

Martinsried/Planegg
More Events

Webcasts

No Webcasts found
Language (EN)
Legal Notice Data Protection